Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Other Gastrointestinal Disorders”

424 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 424 results

Testing effectiveness (Phase 2)Ended earlyNCT05678257
What this trial is testing

NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal NeoplasmsColorectal Adenocarcinoma+2 more
NuCana plc 180
Not applicableTemporarily pausedNCT05233007
What this trial is testing

Upper GI Serial Tumour Biopsies

Who this might be right for
Oesophageal CancerGastric Cancer
The Christie NHS Foundation Trust 300
Early research (Phase 1)Ended earlyNCT02784795
What this trial is testing

LY3039478 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorBreast CancerColon Cancer+2 more
Eli Lilly and Company 94
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT03037385
What this trial is testing

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

Who this might be right for
RET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more
Hoffmann-La Roche 590
Testing effectiveness (Phase 2)Active Not RecruitingNCT05185947
What this trial is testing

Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer

Who this might be right for
Gynecologic CancerGynecologic NeoplasmsPeritoneal Carcinomatosis+7 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)WithdrawnNCT05041972
What this trial is testing

ARX788 in Selected HER2-mutated or HER2-amplified/Overexpressed Solid Tumors (ACE-Pan Tumor-02)

Who this might be right for
HER2 Mutation-Related TumorsHER2 Amplified Solid Tumors
Ambrx, Inc.
Not applicableLooking for participantsNCT05877781
What this trial is testing

PEA in Functional Dyspepsia

Who this might be right for
Dyspepsia and Other Specified Disorders of Function of Stomach
Universitaire Ziekenhuizen KU Leuven 100
Not applicableLooking for participantsNCT06116019
What this trial is testing

Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)

Who this might be right for
Prostate CancerHead and Neck CancerNSCLC+6 more
Charite University, Berlin, Germany 649
Not applicableStudy completedNCT03183609
What this trial is testing

Confirmatory Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA IG)

Who this might be right for
SchizophreniaGluten SensitivitySchizo Affective Disorder
University of Maryland, Baltimore 40
Not applicableUnknownNCT03517332
What this trial is testing

Circulating Tumor DNA Exposure in Peripheral Blood

Who this might be right for
Colorectal CancerPancreatic AdenocarcinomaGastric Cancer+8 more
Quantgene Inc. 10,000
Not applicableNo Longer AvailableNCT01980732
What this trial is testing

68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors

Who this might be right for
Carcinoid TumorsIslet Cell (Pancreatic NET)Other Neuroendocrine Tumors
Andrei Iagaru
Post-approval studies (Phase 4)WithdrawnNCT02213887
What this trial is testing

Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications

Who this might be right for
Psychotic DisordersGastroesophageal Reflux
University of British Columbia
Large-scale testing (Phase 3)Looking for participantsNCT07175272
What this trial is testing

Holy Basil in The Treatment of Dyspepsia

Who this might be right for
Dyspepsia and Other Specified Disorders of Function of Stomach
Mahidol University 27
Early research (Phase 1)UnknownNCT04149691
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies

Who this might be right for
Gastric CancerBladder CancerSquamous Non-small Cell Lung Cancer+4 more
Celon Pharma SA 42
Testing effectiveness (Phase 2)Looking for participantsNCT04930432
What this trial is testing

Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors

Who this might be right for
Solid TumorNon-Small Cell Lung CancerHead and Neck Cancer+1 more
Betta Pharmaceuticals Co., Ltd. 400
Testing effectiveness (Phase 2)Study completedNCT02431676
What this trial is testing

Survivorship Promotion In Reducing IGF-1 Trial

Who this might be right for
Breast CancerProstate CancerLung Cancer+8 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 121
Not applicableLooking for participantsNCT06060990
What this trial is testing

Determination of Copper and Other Trace Elements in Serum Samples From Patients With Biliary Tract Cancers

Who this might be right for
Trace Element Deficiency
Institute of Oncology Ljubljana 20
Not applicableStudy completedNCT05176860
What this trial is testing

Evaluation of Novel Cone-Beam CT for Guidance and Adaptation of Precision Radiotherapy

Who this might be right for
Lung CancerLiver CancerBreast Cancer+1 more
Varian, a Siemens Healthineers Company 30
Large-scale testing (Phase 3)Study completedNCT03465722
What this trial is testing

(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST

Who this might be right for
GIST
Blueprint Medicines Corporation 476
Load More Results